ResearcherNational Cancer Centre JapanActive in the last 2 years
Satoshi Okubo
Matched on ORCID iD 0000-0003-3010-7776; OpenAlex author ID A5103200026. Sources: OpenAlex.
Their work
- Papers
- 4 (first author 2, last author 0)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 15
2019: 1 paper · 2020: 1 paper · 2021: none · 2022: none · 2023: none · 2024: none · 2025: 1 paper · 2026: 1 paper
Papers 4
- ASO Visual Abstract: Prognostic Value of a ≥ 1000 μm Posterior Margin After Gerota's Fascia Resection in Distal Pancreatectomy for Resectable Pancreatic Cancer… First author DOI 10.1245/s10434-025-18389-0↗
- Prognostic Value of a ≥ 1000 μm Posterior Margin After Gerota's Fascia Resection in Distal Pancreatectomy for Resectable Pancreatic Cancer: A Single-Center Ret… First author DOI 10.1245/s10434-025-18173-0↗
- Clinical Utility of Histological and Radiological Evaluations of Tumor Necrosis for Predicting Prognosis in Pancreatic Cancer. Co-author DOI 10.1097/mpa.0000000000001539↗
- Area of residual tumor (ART) can predict prognosis after post neoadjuvant therapy resection for pancreatic ductal adenocarcinoma. Co-author DOI 10.1038/s41598-019-53801-2↗
Closest collaborators
The 15 strongest of 15 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Hisashi Murakami · 2 shared papers, 2025–2026 · strength 0.62
- Paper ASO Visual Abstract: Prognostic Value of a ≥ 1000 μm Posterior Margin After Gerota's Fascia Resection in Distal Pancrea… DOI 10.1245/s10434-025-18389-0↗
- Paper Prognostic Value of a ≥ 1000 μm Posterior Margin After Gerota's Fascia Resection in Distal Pancreatectomy for Resectabl… DOI 10.1245/s10434-025-18173-0↗
- Masaru Matsumura · 2 shared papers, 2025–2026 · strength 0.62
- Paper ASO Visual Abstract: Prognostic Value of a ≥ 1000 μm Posterior Margin After Gerota's Fascia Resection in Distal Pancrea… DOI 10.1245/s10434-025-18389-0↗
- Paper Prognostic Value of a ≥ 1000 μm Posterior Margin After Gerota's Fascia Resection in Distal Pancreatectomy for Resectabl… DOI 10.1245/s10434-025-18173-0↗
- Masaji Hashimoto · 2 shared papers, 2025–2026 · strength 0.62
- Paper ASO Visual Abstract: Prognostic Value of a ≥ 1000 μm Posterior Margin After Gerota's Fascia Resection in Distal Pancrea… DOI 10.1245/s10434-025-18389-0↗
- Paper Prognostic Value of a ≥ 1000 μm Posterior Margin After Gerota's Fascia Resection in Distal Pancreatectomy for Resectabl… DOI 10.1245/s10434-025-18173-0↗
- Naoto Gotohda · 2 shared papers, 2019–2020 · strength 0.19
- Paper Clinical Utility of Histological and Radiological Evaluations of Tumor Necrosis for Predicting Prognosis in Pancreatic … DOI 10.1097/mpa.0000000000001539↗
- Paper Area of residual tumor (ART) can predict prognosis after post neoadjuvant therapy resection for pancreatic ductal adeno… DOI 10.1038/s41598-019-53801-2↗
- Shinichiro Takahashi · 2 shared papers, 2019–2020 · strength 0.19
- Paper Clinical Utility of Histological and Radiological Evaluations of Tumor Necrosis for Predicting Prognosis in Pancreatic … DOI 10.1097/mpa.0000000000001539↗
- Paper Area of residual tumor (ART) can predict prognosis after post neoadjuvant therapy resection for pancreatic ductal adeno… DOI 10.1038/s41598-019-53801-2↗
- Motohiro Kojima · 2 shared papers, 2019–2020 · strength 0.19
- Paper Clinical Utility of Histological and Radiological Evaluations of Tumor Necrosis for Predicting Prognosis in Pancreatic … DOI 10.1097/mpa.0000000000001539↗
- Paper Area of residual tumor (ART) can predict prognosis after post neoadjuvant therapy resection for pancreatic ductal adeno… DOI 10.1038/s41598-019-53801-2↗
- Shin Kobayashi · 1 shared paper, 2020 · strength 0.10
- Motokazu Sugimoto · 1 shared paper, 2020 · strength 0.10
- Horacio Cabral · 1 shared paper, 2020 · strength 0.10
- Masashi Kudo · 1 shared paper, 2020 · strength 0.10
- Yoko Matsuda · 1 shared paper, 2019 · strength 0.09
- Mari A. Mino-Kenudson · 1 shared paper, 2019 · strength 0.09
- Katsuhiko Uesaka · 1 shared paper, 2019 · strength 0.09
- Hirochika Toyama · 1 shared paper, 2019 · strength 0.09
- Soichiro Morinaga · 1 shared paper, 2019 · strength 0.09
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.